Proton pump inhibitors (PPIs), commonly used to treat acid reflux and stomach ulcers, is linked to a more than doubled risk of developing stomach cancer, researchers have claimed in a new study.

See the source article by following the link below:
Proton pump inhibitors (PPIs), commonly used to treat acid reflux and stomach ulcers, is linked to a more than doubled risk of developing stomach cancer, researchers have claimed in a new study.